

Operator of a global pharmaceutical company created to offer bio pharmaceutical products and services. The company specializes in oncology products for solid tumors, hematological malignancies and supportive therapies and also offers products for critical disorders. Its success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades. Among its major competitors, Intas Pharmaceuticals is ranked in 10th place for NPS while Glenmark Pharmaceuticals is 1st, and Lupin is 2nd.